Reproductive aging isn’t just your birthday — it’s biology. In this Deep Dive, Dr. Mike Belkowski breaks down the emerging science of AI in fertility assessment and why the next wave of reproductive medicine will move beyond single-marker thinking (AMH, FSH, AFC, semen analysis) into a multi-dimensional model built on three interconnected pillars: mitochondrial function, oxidative stress, and telomere biology.

You’ll learn why egg and sperm quality decline is fundamentally an energy and redox story, why the most meaningful biomarkers are often hard to use clinically (invasive, destructive, non-standardized), and how AI can realistically change the game through imaging, pattern recognition, and multi-omics integration — without replacing clinicians. We also cover the real-world constraints: data quality, bias, explainability, validation, regulation, and privacy; because the future isn’t hype, it’s precision.

(Educational content only, not medical advice.)

Article Discussed in Episode:

Artificial Intelligence in Assessing Reproductive Aging: Role of Mitochondria, Oxidative Stress, and Telomere Biology

Key Quotes From Dr. Mike:

“Fertility decline happens at the level of energy, oxidative stress, and cellular timekeeping.”

“Oocytes are an ATP-intensive cell type; energy is the limiting factor.”

“ROS isn’t the villain—uncontrolled ROS is the villain.”

“Mitochondria, oxidative stress, and telomeres aren’t separate — they amplify each other.”

“AI won’t replace clinicians—it can integrate complexity humans can’t.”

“The next frontier is multi-layer prediction: hormones + imaging + mitochondrial competence.”

Key points

Reproductive aging is biological, not just chronological.
The “big 3” drivers: mitochondrial dysfunction + oxidative stress + telomere dynamics.
Standard markers (AMH/FSH/AFC; semen analysis) don’t fully predict gamete quality/outcomes.
Oocytes are mitochondria-dense; ATP is required for spindle formation, segregation, fertilization, early development.
Sperm rely on mitochondria for motility, capacitation, DNA integrity.
Mitochondrial biomarkers: mtDNA copy number, membrane potential, ATP, ROS—but many tests are invasive/destructive.
ROS is necessary at physiologic levels; excess ROS drives DNA/lipid/protein damage and reproductive decline.
Telomeres: shorter telomeres correlate with worse female outcomes; male telomere dynamics differ, but oxidative stress still harms telomeres/DNA.
These pillars amplify each other: mito dysfunction → ROS ↑ → telomere damage ↑ → cellular aging ↑.
AI’s current traction: embryo grading, IVF outcome prediction, computer-vision sperm analysis.
Next frontier: AI integrating hormones + imaging + mitochondrial/oxidative/telomere biomarkers + lifestyle/exposures.
Adoption requires explainability, multi-center validation, bias control, privacy, and clear accountability.

Episode timeline

0:19–2:29 Why AI is about to reshape fertility assessment + the 3 pillars framework
2:46–5:32 Mitochondria in eggs/sperm + key mito biomarkers + why testing is hard clinically
5:37–7:42 Oxidative stress: why ROS is both necessary and dangerous + biomarkers + standardization issues
7:42–9:33 Telomeres: female vs male dynamics + the amplification loop (mito ↔ ROS ↔ telomeres)
9:43–11:23 Where AI already works: embryo grading, IVF prediction, sperm analysis + what’s next
11:23–12:34 Real-world constraints: explainability, bias, heterogeneity, validation, regulation, privacy
12:37–15:28 The Energy Code takeaway: fertility as “energy age” + personalized levers + responsible precision
15:35–16:15 Tease: what a next-gen AI fertility clinic could look like

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

EMF-mitigating products: Somavedic (code: BIOLIGHT)

Blue light blocking glasses: Ra Optics (code: BIOLIGHT)

Grounding products: Earthing.com

Stay up-to-date on social media:

Dr. Mike Belkowski:

BioLight: